| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0478540623811426 | 0.35870205 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0478540623811426 | 0.13381793 |
| NSC 134459 | Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) | 0.0478540623811426 | 0.31934442 |
| NSC 21683 | Null | 0.0478540623811426 | 0.37452613 |
| NSC 287069 | Epicorazine A | 0.0478540623811426 | 0.20342488 |
| NSC 31780 | 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) | 0.0478540623811426 | 0.38009475 |
| NSC 330507 | Tanespimycin | 0.0478540623811426 | 0.63574918 |
| NSC 346098 | Null | 0.0478540623811426 | 0.46973515 |
| NSC 361605 | Uracil, 5-fluoro-1-[tetrahydro-5-oxo-3-(trimethylsiloxy)-2-furanyl]-, (2S,trans)- | 0.0478540623811426 | 0.18095022 |
| NSC 372939 | Null | 0.0478540623811426 | 0.47640154 |